A prescription eyedrop used to treat acquired blepharoptosis (low-lying lids) in adults.
Upneeq Oxymetazoline Hydrochloride Ophthalmic Solution 0.1% is an FDA-approved prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes.
HOW TO USE
UPNEEQ is indicated for the treatment of acquired blepharoptosis in adults.
DOSAGE AND ADMINISTRATION:
Instill one drop of UPNEEQ into one or both ptotic eye(s) once daily. Discard the single patient-use container immediately after dosing.
Contact lenses should be removed prior to instillation of UPNEEQ and may be reinserted 15 minutes following its administration.
If more than one topical ophthalmic drug is being used, the drugs should be administered at least 15 minutes between applications.
Your doctor should review your full medical history before prescribing UPNEEQ.
INGREDIENTS
See individual product.